The development of action potential mechanism in a mouse neuronal cell line in vitro

1978 ◽  
Vol 143 (2) ◽  
pp. 349-354 ◽  
Author(s):  
Michihisa Miyake
2002 ◽  
Vol 69 (5) ◽  
pp. 1870-1881 ◽  
Author(s):  
V. Coronas ◽  
F. Féron ◽  
R. Hen ◽  
G. Sicard ◽  
F. Jourdan ◽  
...  

2016 ◽  
Vol 37 (3) ◽  
pp. 405-416 ◽  
Author(s):  
Javier Morán ◽  
Marcos Perez-Basterrechea ◽  
Pablo Garrido ◽  
Elena Díaz ◽  
Ana Alonso ◽  
...  

2006 ◽  
Vol 394 (2) ◽  
Author(s):  
Ginger S. Withers

The ability to control the placement of cells and the assembly of networks in vitro has tremendous potential for understanding the regulation of development as well as for generating artificial tissues. To date, most engineering tools that can place materials with precision are not compatible with the requirements of living cells, and so approaches to tissue engineering have focused on patterning substrates as a way of controlling cell growth rather than patterning cells directly. In this issue of Biochemical Journal, however, Eagles et al. adapt electrohydrodynamic printing technology to ‘print’ living cells from a neuronal cell line on to a substrate. The importance of this approach is that it has the potential for unprecedented control over the position of cells in culture by directly placing them, thus allowing for the systematic assembly of cell networks.


2006 ◽  
Vol 2006 ◽  
pp. 1-13 ◽  
Author(s):  
Mattia Toni ◽  
Enzo Spisni ◽  
Cristiana Griffoni ◽  
Spartaco Santi ◽  
Massimo Riccio ◽  
...  

It has been reported that cellular prion protein (PrPc) is enriched in caveolae or caveolae-like domains with caveolin-1 (Cav-1) participating to signal transduction events by Fyn kinase recruitment. By using the Glutathione-S-transferase (GST)-fusion proteins assay, we observed that PrPc strongly interacts in vitro with Cav-1. Thus, we ascertained the PrPc caveolar localization in a hypothalamic neuronal cell line (GN11), by confocal microscopy analysis, flotation on density gradient, and coimmunoprecipitation experiments. Following the anti-PrPc antibody-mediated stimulation of live GN11 cells, we observed that PrPc clustered on plasma membrane domains rich in Cav-1 in which Fyn kinase converged to be activated. After these events, a signaling cascade through p42/44 MAP kinase (Erk 1/2) was triggered, suggesting that following translocations from rafts to caveolae or caveolae-like domains PrPc could interact with Cav-1 and induce signal transduction events.


Biomolecules ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 287
Author(s):  
Mohammad Sarif Mohiuddin ◽  
Tatsuhito Himeno ◽  
Yuichiro Yamada ◽  
Yoshiaki Morishita ◽  
Masaki Kondo ◽  
...  

Although diabetic polyneuropathy (DPN) is a frequent diabetic complication, no effective therapeutic approach has been established. Glucagon is a crucial hormone for glucose homeostasis but has pleiotropic effects, including neuroprotective effects in the central nervous system. However, the importance of glucagon in the peripheral nervous system (PNS) has not been clarified. Here, we hypothesized that glucagon might have a neuroprotective function in the PNS. The immortalized rat dorsal root ganglion (DRG) neuronal cell line 50B11 was treated with methylglyoxal (MG) to mimic an in vitro DPN model. The cells were cultured with or without glucagon or MG. Neurotoxicity, survival, apoptosis, neurite projection, cyclic adenosine monophosphate (cAMP), and protein kinase A (PKA) were examined. Glucagon had no cytotoxicity and rescued the cells from neurotoxicity. Cell survival was increased by glucagon. The ratio of apoptotic cells, which was increased by MG, was reduced by glucagon. Neurite outgrowth was accelerated in glucagon-treated cells. Cyclic AMP and PKA accumulated in the cells after glucagon stimulation. In conclusion, glucagon protected the DRG neuronal cells from MG-induced cellular stress. The cAMP/PKA pathway may have significant roles in those protective effects of glucagon. Glucagon may be a potential target for the treatment of DPN.


2007 ◽  
Vol 109 (2) ◽  
pp. 111-121 ◽  
Author(s):  
Sophie Lakard ◽  
Eric Lesniewska ◽  
Germaine Michel ◽  
Boris Lakard ◽  
Nadege Morrand-Villeneuve ◽  
...  

Author(s):  
R. L. Moses ◽  
J. W. Haycock

The study of neuronal differentiation would be facilitated by the availability of a homogeneous neuronal cell line capable of differentiation. Ronnett, et al. have cloned a cell line (HCN-1A) from the cerebral cortex of a megalencephalic patient. These cells undergo process formation after treatment with nerve growth factor and cAMP and, after differentiation, express numerous neuronal markers. Subsequent to treatment, the normally epithelioid HCN-1A cells became highly branched, often within the first two hours (FIG. 1A), creating a meshwork of closely associated processes with several orders of branching (FIG 1B). Not all cells remained in the differentiated state, resulting in phenotypically mixed cultures (FIG. 1A). Light microscopy of treated cells suggested that process formation occurred via cytoplasmic retraction rather than neurite outgrowth. In situ TEM analysis revealed that the cell bodies (FIG. 2A) of treated and untreated cells both possessed a number of neuronal characteristics including large euchromatic nuclei with prominent nucleoli, numerous profiles of rough endoplasmic reticulum (FIG. 2B), and prominent Golgi lamellae (FIG. 2C). Processes (FIG. 2D) were not ultrastructurally identifiable as axonal versus dendritic. Longitudinally arranged microtubules and intermediate filaments were both present in the majority of processes.


2012 ◽  
Vol 302 (8) ◽  
pp. C1162-C1173 ◽  
Author(s):  
Neeru M. Sharma ◽  
Hong Zheng ◽  
Yi-Fan Li ◽  
Kaushik P. Patel

We have previously observed an increased of angiotensin II (ANG II) type 1 receptor (AT1R) with enhanced AT1R-mediated sympathetic outflow and concomitant downregulation of neuronal nitric oxide (NO) synthase (nNOS) with reduced NO-mediated inhibition from the paraventricular nucleus (PVN) in rats with heart failure. To test the hypothesis that NO exerts an inhibitory effect on AT1R expression in the PVN, we used primary cultured hypothalamic cells of neonatal rats and neuronal cell line NG108-15 as in vitro models. In hypothalamic primary culture, NO donor sodium nitroprusside (SNP) induced dose-dependent decreases in mRNA and protein of AT1R (10−5 M SNP, AT1R protein was 10 ± 2% of control level) while NOS inhibitor NG-monomethyl-l-arginine (l-NMMA) induced dose-dependent increases in mRNA and protein levels of AT1R (10−5 M l-NMMA, AT1R protein was 148 ± 8% of control level). Similar effects of SNP and l-NMMA on AT1R expression were also observed in NG108-15 cell line (10−6 M SNP, AT1R protein was 30 ± 4% of control level while at the dose of 10−6 M l-NMMA, AT1R protein was 171 ± 15% of the control level). Specific inhibition of nNOS, using antisense, caused an increase in AT1R expression while overexpression of nNOS, using adenoviral gene transfer (Ad.nNOS), caused an inhibition of AT1R expression in NG108 cells. Antisense nNOS transfection augmented the increase while Ad.nNOS infection blunted the increase in intracellular calcium concentration in response to ANG II treatment in NG108 cells. In addition, downregulation of AT1R mRNA as well as protein level in neuronal cell line in response to S-nitroso- N-acetyl pencillamine (SNAP) treatment was blocked by protein kinase G (PKG) inhibitor, while the peroxynitrite scavenger deforxamine had no effect. These results suggest that NO acts as an inhibitory regulator of AT1R expression and the activation of PKG is the required step in the regulation of AT1R gene expression via cGMP-dependent signaling pathway.


Sign in / Sign up

Export Citation Format

Share Document